ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002

Ethics Commission to Meet In L.A.

September 4, 1981

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

Cancergrams Cost $840 Year For All

December 2, 1977